Global Eating Disorder Therapy Market Overview
Food and water are the two basic necessities that every individual requires for a hassle-free living. Everyone loves to have delicious food so that the taste buds burst out with happiness. But unknowingly people also suffer from various food disorders which sometimes are not recognizable, for example, overeating, night cravings for food, and feeling empty stomach after having a proper diet. Eating disorders have been growing for the last 50 years due to the changing lifestyles of people and food habits. Although eating disorders can affect people of any age, mainly adolescents and young adults are at high risk. According to the National Association of Anorexia Nervosa and Associated Disorders in January 2021, 9% of the world is affected by food disorders worldwide, with 28.8 million of the population in the U.S. having eating disorders. Anorexia Nervosa and Bulimia Nervosa are the two different kinds of food disorders that mainly affect teenagers and early twenties with preponderance in women and girls. Eating disorders are basically enduring conditions but it hampers both mental and physical health. All healthcare providers should provide proper health assessments about eating habits. Eating Disorder Therapy Market is still under research and development.
Cause of Eating Disorders in the Society
There are various causes of eating disorders, sometimes it is genetically passed on by parents to their children. Genetics has a significant contribution and may predispose individuals to eating disorders. Secondly, the major role is played by biochemistry, it states that people with eating disorders have an abnormal level of chemicals that regulate the appetite of the body, sleep, mood – swings, and stress levels. Culture and environment also play a significant role in eating disorders, sometimes our eating habits totally depend on the kind of environment.
Eating disorders are psychic disturbances characterized by a negative attitude to food, weight, and body image, with inappropriate eating practices. They can become life-threatening if not treated and have a profound effect on both the physical and mental health of a person. The key features of eating disorders include disruption of eating patterns, compulsive thoughts, negative body image, and loss of control. Common forms include Anorexia Nervosa, Bulimia Nervosa, Avoidant/Restrictive Food Intake Disorder, and Binge-Eating Disorder. Anorexia nervosa is characterized by severe calorie restriction, having a distorted body image, and a fear of weight increase. There are cycles of binge eating and purging behaviors in bulimia Nervosa. In binge eating disorder frequent periods of uncontrollably excessive eating are a feature frequently accompanied by feelings of guilt and shame.
Global Eating Disorder Therapy Market Drivers & Restraints
Increasing psychological disorder drives the market
Increasing psychological disorders in turn increase the market for eating disorders, as eating disorder is related to psychological conditions. Further, sometimes eating disorders are inherited genetically therefore there is an increase in the eating disorder population. Moreover, changing lifestyle also affects the psychological disorder which in turn fosters the global eating disorder market. According to John Hopkins, 26% of Americans aged 18 and older or approximately 1 in 4 suffer from mental disorders, which in turn may lead to eating disorders.
Further, to spread of pandemic Covid- 19 and lockdown resulted in an increasing population with eating disorders which also supported the growth of the market.
Side effects from the therapy and unfavorable reimbursement policy
People suffering from eating disorders have considerable side effects from the therapy, such as swollen cheeks, puffy cheeks, and swollen glands. Further, though the disease is around 30 years old, there are no strict reimbursement policies for eating disorder therapy. Many insurance companies don’t reimburse the treatment bill, which hampers the eating disorder treatment market.
Treatment of binge eating disorder, bulimia nervosa, and anorexia nervosa forms a consolidated significant economic activity in the eating disorder therapy market. The growth in awareness, early diagnosis, changing treatment patterns, and insurance coverage are drivers of this industry. Some issues that this market faces include stigma, high prices of treatment, lack of qualified practitioners, and limitations in insurance coverage. Earlier detection of eating problems may be potentiated by better screening and education programs, thus enabling an earlier stage of intervention and treatment. Despite these challenges, the market continues to grow.
Global Eating Disorder Therapy Market Segmentations & Regional Insights
Global Eating Disorder Therapy Market is segmented based on type, treatment, patient, route of administration, end-use, and by region.
Based on the type, the Eating Disorder Therapy market is classified into Anorexia Nervosa, Binge Eating Disorder, bulimia Nervosa, Pica, Avoidant/Restrictive Food Intake Disorder, Rumination Disorder, Night Eating Syndrome, Purging Disorder, and Others.
Further, on the basis of treatment, the target market is segmented into Medications, Therapy, and Others.
On the basis of patients, the target market is segmented into inpatients and outpatients, and on the basis of the role of administration target market is segmented into Oral, Parenteral, and Others.
On the basis of end–users, the market is segmented into Hospitals, Clinics, and Others, where hospitals are expected to dominate the market over the forecast period.
Regional Insights:
On the basis of region, the Global Eating Disorder Therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. On a country level, Japan is expected to dominate in Asia Pacific because it has a high number of cases of eating disorders. Japan is followed by Hong – Kong, Taiwan, South Korea, and Singapore.
Further, North America eating disorder therapy market also shows a significant share. For instance, according to the National Institute of Eating Disorders in 2016, approx. one million people present in Canada met the diagnostic criteria for eating disorders. National Comorbidity Survey Replication in the U.S. stated that binge eating disorder is commonly found in adults and affects approx. 2.8 million people in the United States.
Report Scope:
Attribute |
Details |
Base year for estimation |
2020 |
Forecast period |
2020 – 2030 |
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
Market Segmentation |
By Type - Anorexia Nervosa, Binge Eating Disorder, bulimia Nervosa, Pica, Avoidant/Restrictive Food Intake Disorder, Rumination Disorder, Night Eating Syndrome, Purging Disorder, Others By Patients - Inpatients, Outpatients By Treatment - Medications, Therapy, Others By Route Of Administration - Oral, Parenteral, Others By End – Users - Hospitals, Clinics, Others Distribution Channel - Hospital, Pharmacy, Retail Pharmacy, Others By Region - North America, Europe, Asia Pacific, Latin America And Middle East & Africa) – Market Trends, Analysis, And Forecast Till 2029.
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Global Eating Disorder Therapy Market report based on Type, patients, treatment, Route of administration, distribution channel, End user, region.
Global Eating Disorder Therapy Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Eating Disorder Therapy Market Competitive Landscape & Key Players
The key players operating in the Eating Disorder Therapy Market involves various companies, which includes Chronos Therapeutics, Shire US Inc., Eli Lilly and Company, Sunovion Pharmaceuticals Inc., Promises Behavioral Health, Pyramid Healthcare (Tapestry Eating Disorder Services), Timberline Knolls, Rosewood Centers for Eating Disorders, Walden Behavioral Care.
Most of key players and startups are involved in innovation in technology to improve the eating disorder therapy treatment market. For instance, EQUIP co – founders Erin Parks and Krishna saffran in February 2021 launched the startup to make gold standard treating disorder treatments which is accessible to everyone it is family based treatment.
Global Eating Disorder Therapy Market Company Profile
- Chronos Therapeutics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Shire US Inc.
- Eli Lilly and Company
- Sunovion Pharmaceuticals Inc.
- Promises Behavioral Health
- Pyramid Healthcare (Tapestry Eating Disorder Services)
- Timberline Knolls
- Rosewood Centers for Eating Disorders
- Walden Behavioral Care.
“*” marked represents similar segmentation in other categories in the respective section
Future Aspect
As Global Eating Disorder Therapy Market is developing and increasing due to certain different food disorders which people are facing in today’s genera due to changing lifestyle and eating habits. Psychological effects like stress, mood swings also affects the body physically and mentally which disturbs the eating habits and leads to food disorders.
FAQs
Global Eating Disorder Therapy Market is segmented into type, patients, treatment, role of administration, end – users.
Current major challenges are the identification of food disorders a person is going through.
Inherited genes, physiological effects and changing lifestyle are the major cause of the global eating disorder therapy market.